azacitidine has been researched along with Leukemia, Pre-B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, WK; Kees, UR; Welch, MD | 1 |
| André, MC; Bühring, HJ; Ebinger, M; Handgretinger, R; Hartwig, UF; Herr, W; Kübler, A; Lang, P; Mezger, M; Münz, C; Oevermann, L; Witte, KE; Woiterski, J | 1 |
| Barwe, SP; Gopalakrishnapillai, A; Quagliano, A | 1 |
| Ardekani, AM; Jeddi Tehrani, M; Soleymani Fard, S | 1 |
4 other study(ies) available for azacitidine and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia.
Topics: Azacitidine; Cells, Cultured; Child; Connective Tissue Growth Factor; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Leukemic; Humans; Hydroxamic Acids; Jurkat Cells; Neoplasm Proteins; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sequence Analysis, DNA | 2013 |
Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice.
Topics: Animals; Antineoplastic Agents; Azacitidine; Child; Cytokines; Cytotoxicity, Immunologic; Disease Models, Animal; DNA Methylation; Genotype; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Natural; Mice; Mice, Inbred NOD; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Receptors, KIR; Transplantation, Heterologous | 2014 |
Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.
Topics: Animals; Azacitidine; Coculture Techniques; DNA Modification Methylases; Drug Resistance, Neoplasm; Epigenesis, Genetic; Heterografts; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Osteoblasts; Panobinostat; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 2017 |
Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Caspase 3; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Decitabine; Dinoprostone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2012 |